FDA finds Amneal Pharma used contaminated IV bags for sterile drug
In a startling failure of quality control, Amneal Pharmaceuticals relied on contaminated bags for a sterile injectable drug…
Amid tariff wars, Canada’s pharma services industry sees opportunity
 Key Insights Canadian firms are positioning the country as a hub for pharmaceutical services Some industry insiders…
Statins should be available over the counter
Welcome to The Workup, a new First Opinion column from Vishal Khetpal. There’s a saying in medicine: Statins…
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Leal Therapeutics is developing first-in-class therapeutics to correct metabolic imbalances in the brain for treatment of high unmet…
MAHA loves dietary supplements. But that hasn’t led to gains in Washington — yet.
An avid consumer of dietary supplements, Health and Human Services Secretary Robert F. Kennedy Jr. has surrounded himself…
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
Hypothalamic neurons help maintain blood sugar during daily activities
The brain controls the release of glucose in a wide range of stressful circumstances, including fasting and low…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines
Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…
Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…
What are PBMs? How a bipartisan push could affect prescriptions
Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications and driving up costs.See the…
Wealthy countries pay more for essential medicines, but the cost burden is far lower, study finds
Published on 17/08/2025 – 9:30 GMT+2 ADVERTISEMENT Wealthy countries may pay steep prices for medicines, but once their…